Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

ClinicalTrials.gov ID: NCT05259033

Public ClinicalTrials.gov record NCT05259033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52 Week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Once Weekly Semaglutide, Both Treatment Arms With or Without Oral Anti Diabetic Drugs, in Participants With Type 2 Diabetes Inadequately Controlled With a GLP 1 Receptor Agonist. COMBINE 2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to semaglutide taken once a week in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar level in people with type 2 diabetes compared to semaglutide. Participants will either get IcoSema or semaglutide. Which treatment participants get is decided by chance. IcoSema is a new medicine that doctors cannot prescribe. Doctors can already prescribe semaglutide in many countries. Participants will get IcoSema or semaglutide, which they must inject once a week with a pen, which has a small needle, in a skin fold in the thigh, upper arm, or stomach. The study will last for about 1 year and 1 month. Participants will have 18 clinic visits, 34 phone/video calls with the study doctor, and 4 contacts with the site that can either be clinic visits or phone/video calls. At 11 clinic visits participants will have blood samples taken. At 7 clinic visits participants cannot eat or drink (except for water) for 8 hours before the visit. Women cannot take part if pregnant, breast-feeding or plan to get pregnant during the study period.

Study identification

NCT ID
NCT05259033
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
683 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 10, 2022
Primary completion
Dec 12, 2023
Completion
Jan 15, 2024
Last update posted
Jun 11, 2026

2022 – 2024

United States locations

U.S. sites
76
U.S. states
30
U.S. cities
68
Facility City State ZIP Site status
Univ of AL at Birmingham_BRM Birmingham Alabama 35294
Pri Med Grp dba/Gil Ctr Fam Gilbert Arizona 85296
Phoenician Centers for Research & Innovation PCRI Phoenix Arizona 85021
Clinical Research Institute of Arizona Sun City West Arizona 85375
John Muir Physicians Network Concord California 94520
Scripps Whittier Diabetes Inst La Jolla California 92037
Clinical Trials Research_Sacramento Lincoln California 95821
Downtown LA Res Ctr. Inc. Los Angeles California 90017
Velocity Clin Res Los Angeles Los Angeles California 90017
Velocity Clin Res Wstlke Los Angeles California 90057
Valley Clinical Trials, Inc. Northridge California 91325
San Diego Family Care_San Diego San Diego California 92111
Premier Medical Center, Inc. Toluca Lake California 91602
Northeast Research Institute Fleming Island Florida 32003
Encore Medical Research LLC Hollywood Florida 33024
Northeast Res Inst. Inc. Jacksonville Florida 32204
Est Cst Inst for Rsrch,Jksnvil Jacksonville Florida 32216
University Of Miami Miami Florida 33136
South Broward Research LLC Miramar Florida 33027
Adult Medicine of Lake County, Inc. Mt. Dora Florida 32757
Clinical Neuroscience Solution Orlando Florida 32801
Florida Institute For Clinical Research Orlando Florida 32825
Oviedo Medical Research, LLC Oviedo Florida 32765
Metabolic Research Institute Inc West Palm Beach Florida 33401
Javara/Privia Med Grp GA,LLC Albany Georgia 31707
Endo Res Solutions Inc Roswell Georgia 30076
East West Med Res Inst Honolulu Hawaii 96814
Saltzer Medical Group Research Nampa Idaho 83686-6011
Cedar-Crosse Research Center Chicago Illinois 60607
Macoupin Research Group Gillespie Illinois 62033
Endeavor Health Skokie Illinois 60077
Central Illinois Diabetes and Clinical Research Springfield Illinois 62711
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383
Iowa Diab & Endo Res Center West Des Moines Iowa 50266
Cotton-O'Neil Diab & Endo Ctr Topeka Kansas 66606
L-MARC Research Center Louisville Kentucky 40213
Four Rivers Clinical Research Inc Paducah Kentucky 42001
Ileana J Tandron APMC Slidell Louisiana 70461-4231
MedStar Hlth Res Institute Hyattsville Maryland 20782
ActivMed Practice & Research LLC Methuen Massachusetts 01844
Northern Pines Hlth Ctr, PC Buckley Michigan 49620
Univ of Nebraska Medical CTR Omaha Nebraska 68198-3020
Palm Research Center Inc-Vegas Las Vegas Nevada 89148
Southern New Hampshire Diabete Nashua New Hampshire 03060
John J Shelmet, MD Lawrenceville New Jersey 08648
Albuquerque Clin Trials, Inc. Albuquerque New Mexico 87102
Endocrine Associates of Long Island, PC Smithtown New York 11787
Southgate Medical Group, LLP West Seneca New York 14224
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Accellacare Wilmington North Carolina 28401
Diab & Endo Assoc of Stark Co Canton Ohio 44718
New Venture Medical Research Wadsworth Ohio 44281
Thomas Jefferson Univ Di Rsrch Ctr Philadelphia Pennsylvania 19107
Hillcrest Clinical Research Simpsonville South Carolina 29681-1538
Palmetto Clinical Research Summerville South Carolina 29485
AM Diabetes And Endocrinology Center Bartlett Tennessee 38133
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404
Amarillo Med Spec LLP Amarillo Texas 79106
Texas Diab & Endo, P.A. Austin Texas 78731
Texas Diabetes & Endocrinology Austin Texas 78749
Osvaldo A. Brusco MD Corpus Christi Texas 78414
Cedar Research Dallas Texas 75038
North Texas Endocrine Center Dallas Texas 75231
UT Southwestern Med Cntr Dallas Texas 75390-9302
Diabetes and Thyroid Ctr of FW Fort Worth Texas 76132
PrimeCare Medical Group Houston Texas 77024
DCOL Ctr for Clin Res Longview Texas 75605
Texas Diabetes & Endocrinology_Round Rock Round Rock Texas 78681
NE Clin Res of San Antonio San Antonio Texas 78233
Sugar Lakes Family Practice PA Sugar Land Texas 77479
Hillcrest Family Health Center Waco Texas 76710
Wade Family Medicine Bountiful Utah 84010
Chrysalis Clinical Research St. George Utah 84790
Javara Inc. / Privia Medical Group LLC_Forest Forest Virginia 24551
Javara Inc/Privia Md GpLLC Fst Forest Virginia 24551
TPMG Clinical Research Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05259033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05259033 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →